Basic and Diluted Net Income Per Share (Tables)

3 Months Ended

Mar. 31, 2026

Earnings Per Share [Abstract]

Summary of Basic Net Income (Loss) Per Share of Class A and Class B Common Stock

The following table sets forth the computation of net income attributable to the Company used to compute basic net income per share of Class A and Class B common stock for the three months ended March 31, 2025 and 2026.

(in thousands)	Three Months Ended March 31, 2025			Three Months Ended March 31, 2026
Numerator:
Net income	$	9,273		$	13,544
Less net income (loss) attributable to non-controlling interests		(175	)		249
Net income attributable to Guardian Pharmacy Services, Inc.	$	9,448		$	13,295

Summary of Basic and Diluted Net Income Per Share of Class A and Class B Common Stock

The following table sets forth the computation of basic and diluted net income per share of Class A and Class B common stock (in thousands, except per share amounts):

	Three Months Ended March 31, 2025				Three Months Ended March 31, 2026
	Class A		Class B		Class A		Class B
Basic net income per share attributable to common stockholders
Numerator:
Allocation of net income attributable to Guardian Pharmacy Services, Inc.	$	1,490	$	7,958	$	7,738	$	5,557
Denominator:
Weighted average number of shares of Class A and Class B common stock outstanding		9,787		52,256		36,855		26,466
Basic net income per share attributable to common stockholders	$	0.15	$	0.15	$	0.21	$	0.21
Diluted net income per share attributable to common stockholders
Numerator:
Allocation of net income attributable to Guardian Pharmacy Services, Inc.	$	1,490	$	7,958	$	7,738	$	5,557
Denominator:
Number of shares used in basic computation		9,787		52,256		36,855		26,466
Dilutive Restricted Stock Units and Class A and B Common Stock		137		733		216		155
Weighted average shares of Class A and Class B common stock outstanding used to calculate diluted net income per share		9,924		52,989		37,071		26,621
Diluted net income per share attributable to common stockholders	$	0.15	$	0.15	$	0.21	$	0.21